ALHYDRAN WITH HIGH UV PROTECTION
Scar cream with spf

In addition to ALHYDRAN medical skin care, ALHYDRAN is now available with high UV protection. This is a logical development: It has long been known that UV rays can damage healthy skin.

It is therefore no surprise that the European directives for the aftercare of wounds and scars explicitly state that the damaged skin barrier needs to be protected against UV rays1. As the skin is at its most vulnerable at this stage.

 

ALHYDRAN SPF30. The proven ‘3-in-1 formula’:

1. Good skin hydration
2. Skin barrier recovery
3. High protection against UV rays

 

Whether the weather is cloudy or sunny, the European directive is clear about aftercare of the damaged skin barrier: avoid the sun and regularly apply a cream with high UV protection. This treatment must be routinely followed with scars, in burn aftercare and after dermatological treatment like laser therapy, chemical peeling, actinic keratosis, etc.

Studies2,3 have shown that ultraviolet (UV) radiation:

  • Disturbs the skin’s healing process
  • Increases the chance of permanent discolouration of the scar
  • Makes the scar more noticeable

Which is why we developed ALHYDRAN with SPF factor 30. High-level sun protection and, at the same time, the results you have come to expect from ALHYDRAN. It is the ideal solution when you cannot avoid going in the sun.

  1. Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, Téot L. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg.2014 Aug;67(8):1017-25.
  2. Haedersdal M, Bech-Thomsen N, Poulsen T, Wulf HC. Ultraviolet exposure influences laser-induced wounds, scars, and hyperpigmentation: a murine study. Plast Reconstr Surg 1998; 101:1315e22. Due E, Rossen K, Sorensen LT, Kliem A,
  3. Karlsmark T, Haedersdal M. Effect of UV irradiation on cutaneous cicatrices: a randomized, controlled trial with clinical, skin reflectance, histological, immunohistochemical and biochemical evaluations. Acta Derm Venereol 2007;87: 27e32.